3 ms·
How that compares to the announcement from https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-astrazeneca-authorisation-eu https://www.ema.europa
by krzyk 6y ago
How that compares to the announcement from https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-astrazeneca-authorisation-eu https://www.ema.europa.eu/en/news/ema-recommends-covid-19-va... where they state the the efficacy is 59.5%?
Is it a different dose or different timeline?
- mrtksn 6y ago“The initial data from Astra and Oxford last month appeared positive but raised concern over how much protection the shot would offer after the trials produced two different results from two dosing regimens. The partners said their vaccine was 90% effective when a half-dose was given before a full-dose booster, and that two full doses showed an efficacy of 62%.” https://www.bloomberg.com/news/articles/2020-12-08/astra-vaccine-is-effective-but-leaves-questions-in-older-ages https://www.bloomberg.com/news/articles/2020-12-08/astra-vac... Turks also find that the Sinovac vaccine is %91 effective when others reported less. I guess it depends on the variant, on what do you understand by “protected” or on how much you want it to work.
- lbeltrame 6y agoThe data the EMA (at least, the public stuff) is from the first "lock" of the data for analysis - November 4th. The current preprint from Oxford is from about one month later.
- sgt101 6y agoI think that the early oxford trials reported infections from day 1 of the shot, later reports are talking about what happens after 21 days.